Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Hepatobiliary and pancreatic cancer

  • Open Access
    Chimeric antigen receptor macrophages: a new frontier in hepatocellular carcinoma treatment
    Rainbow Wing Hei Leung, Clarence Tsun Ting Wong and Terence Kin Wah Lee
    Cancer Biology & Medicine October 2025, 22 (10) 1127-1131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0427
  • Open Access
    Targeting mitochondrial dysfunction to intervene in liver cancer
    Maomao Li, Siyao Liang, Le Chang, Bingyan Lu, Jiahua Cheng, Tian Yang, Ying Wu, Yuhong Lyu, Xiaochan He and Changwu Yue
    Cancer Biology & Medicine October 2025, 22 (10) 1181-1209; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0180
  • Open Access
    Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma
    Xiaoqing Ma, Chenyang Meng, Xuejing Shi, Zhaoyu Zhang, Qiuli Li, Hongwei Wang, Yuexiang Liang, Song Gao, Xiuchao Wang, Chuntao Gao, Jian Wang, Weidong Ma, Yukuan Feng, Shuo Li, Xingyun Chen, Wei Li, Shangheng Shi, Tianxing Zhou, Jun Yu and Jihui Hao
    Cancer Biology & Medicine October 2025, 22 (10) 1255-1266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0181
  • Open Access
    Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma
    Jie Xiang, Yukai Li, Shengmin Mei, Zhiyan Ou, Li Wang, Yang Ke and Zhiwei Li
    Cancer Biology & Medicine August 2025, 22 (8) 928-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0150
  • Open Access
    Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study
    Lunan Qi, Jingxuan Xu, Yuanyuan Chen, Zhan Lu, Min Zhou, Yingwu Huang, Yongchi Ling, Hai Huang, Yuchong Peng, Tao Peng, Bangde Xiang and Liang Ma
    Cancer Biology & Medicine August 2025, 22 (8) 964-987; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0514
  • Open Access
    Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
    Nawaz Khan, Umar Raza, Syed Aqib Ali Zaidi, Muhadaisi Nuer, Kayisaier Abudurousuli, Yipaerguli Paerhati, Alifeiye Aikebaier and Wenting Zhou
    Cancer Biology & Medicine July 2025, 22 (7) 762-788; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0122
  • Open Access
    GPRC5A/CXCL8/NLRP3-mediated neutrophil extracellular traps drive gemcitabine-nab-paclitaxel resistance in pancreatic adenocarcinoma
    Tianyi Zhu, Qianwen Yang, Xiaozhe Qian, Xiuqi Wu, Jianchen Fang, Yuli Lin, Yukuan Feng, Jian Gao and Qing Xia
    Cancer Biology & Medicine July 2025, 22 (7) 832-853; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0040
  • Open Access
    Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis
    Li Yuan, Yue Wang, Junjie Cheng, Shilin Lin, Aying Ma, Kunchao Li, Yiming Zheng, Zhaochong Zeng, Aiwu Ke, Chao Gao and Shisuo Du
    Cancer Biology & Medicine April 2025, 22 (4) 396-411; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0544
  • Open Access
    Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
    Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye
    Cancer Biology & Medicine April 2025, 22 (4) 412-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
  • Open Access
    Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing prospective phase II study
    Xingyun Chen, Shuo Li, Chuntao Gao, Wei Wang, Haorui Li, Yuxiao Liu, Rui Liu and Jihui Hao
    Cancer Biology & Medicine January 2025, 22 (1) 67-76; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0287

Pages

  • Next
  • 1
  • 2
  • Cancer epidemiology (26)
  • Cancer immunology and immunotherapy (49)
  • Gastrointestinal cancer (28)
  • Gynecologic cancer (14)
  • Health Services
    • Cardiology
  • Hematologic tumor and lymphoma (13)
  • Hepatobiliary and pancreatic cancer (19)
  • Lung cancer (15)
  • Breast cancer (21)

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire